文献速递甲状腺与颈部外科围术期管理与 ERAS

全甲状腺切除术后低甲状旁腺功能补充治疗中活性维生素D致高钙血症的危险因素

Risk factors for hypercalcemia induced by active vitamin D derivatives during supplementation for post-total thyroidectomy hypoparathyroidism.
PubMed 文献 · Surgery · 2026-05-05

该回顾性研究分析198例全甲状腺切除术后需补充治疗的低甲状旁腺功能伴低钙血症患者,其中28例(14%)发生医源性高钙血症,均出现在术后第一个月内,25%需再住院。高钙血症组术后早期甲状旁腺激素水平显著更低,且活性维生素D启用更早。术前指标及术后血钙、血磷总体趋势均未能预测该并发症。

要点

  • 全甲状腺切除术后低甲状旁腺功能补充治疗中约1/7发生医源性高钙血症。
  • 高钙血症均发生于术后第一个月内,25%需再住院。
  • 术后早期甲状旁腺激素低和活性维生素D启用早与高钙血症相关。

核心结论

  • 医源性高钙血症约占术后低甲状旁腺功能病例的1/7,可能较严重并需再住院。
  • 高钙血症与术后早期低甲状旁腺激素水平及更早启用活性维生素D相关。

研究设计与样本

  • 回顾性分析2018至2025年Lille大学医院198例全甲状腺切除术后发生低甲状旁腺功能伴低钙血症需补充治疗(钙、镁及活性维生素D)的患者。
  • 分为医源性高钙血症组(28例)与补充治疗下无并发症组(170例),比较临床、生物学及治疗参数。

主要发现

  • 医源性高钙血症发生率为14%(28/198),均出现在术后第一个月内,其中25%需住院。
  • 两组在年龄、性别、体重指数、手术指征、手术类型、术前血钙、25-羟基维生素D、甲状旁腺激素及促甲状腺激素方面相当。
  • 高钙血症组术后第1天和第2天甲状旁腺激素显著更低(P < .05)。
  • 高钙血症组活性维生素D启用更早(1.14 ± 0.65 vs 1.60 ± 0.95天,P = .002)。
  • 术前指标、血钙和血磷总体趋势及术后低钙血症预测评分均未预测医源性高钙血症。

临床怎么用

  • 术后早期应密切监测钙磷谱,尤其在术后前几周。
  • 对术后甲状旁腺激素低者及早期启用活性维生素D者,应谨慎调整补充剂量。

局限性

  • 回顾性单中心研究,样本量有限。
  • 医源性高钙血症组仅28例,统计效能可能受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypoparathyroidism with hypocalcemia is a frequent complication of total thyroidectomy, occurring in 20%-30% of cases, managed by supplementation, sometimes requiring active vitamin D, which can induce iatrogenic hypercalcemia. Predictive factors for this complication remain poorly defined. METHODS: We retrospectively analyzed 198 patients who underwent total thyroidectomy at Lille University Hospital between 2018 and 2025 and developed postoperative hypoparathyroidism with hypocalcemia requiring supplementation (calcium, magnesium, and active vitamin D). Patients were divided into those who developed iatrogenic hypercalcemia (28 patients) and those with an uncomplicated course under supplementation (170 patients). Clinical, biological, and therapeutic parameters were compared. RESULTS: Iatrogenic hypercalcemia occurred in 14% (28/198), always within the first postoperative month; 25% of these required hospitalizations. The 2 groups were comparable for age, sex, body mass index, surgical indications, type of procedure, preoperative serum calcium, 25-hydroxyvitamin D, parathyroid hormone, and thyroid-stimulating hormone. Patients with hypercalcemia had significantly lower early postoperative parathyroid hormone (postoperative day 1 and postoperative day 2, P < .05) and received active vitamin D earlier (1.14 ± 0.65 vs 1.60 ± 0.95 days, P = .002). Neither the preoperative measures, nor the overall trends in serum calcium and phosphate, nor the predictive score for postoperative hypocalcemia predicted iatrogenic hypercalcemia. CONCLUSION: Iatrogenic hypercalcemia complicates approximately 1 in 7 cases of postoperative hypoparathyroidism. This complication may be severe and may require rehospitalization. Hypercalcemia appears to be associated with low early postoperative parathyroid hormone levels and earlier initiation of active vitamin D. These results emphasize the importance of cautious dose adjustment of supplementation and close monitoring of the calcium-phosphate profile during the first postoperative weeks.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Kuzmova M, Marciniak C, Gobert M, et al. Risk factors for hypercalcemia induced by active vitamin D derivatives during supplementation for post-total thyroidectomy hypoparathyroidism. Surgery. 2026. PMID: 42336710. doi:10.1016/j.surg.2026.110300

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。